GENEVA: Six African countries have been chosen to establish their own mRNA vaccine production, the World Health Organization said Friday, with the continent largely shut out of access to COVID-19 jabs.
Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia were selected as the first recipients of technology from the WHO’s global mRNA vaccine hub, in a push to ensure Africa can make its own jabs to fight the COVID-19 and other diseases.
“No other event like the COVID-19 pandemic has shown that reliance on a few companies to supply global public goods is limiting, and dangerous,” WHO chief Tedros Adhanom Ghebreyesus said.
“The best way to address health emergencies and reach universal health coverage is to significantly increase the capacity of all regions to manufacture the health products they need.”
Tedros has continually called for equitable access to vaccines in order to beat the pandemic, and rails against the way wealthy nations have hogged doses, leaving Africa lagging behind other continents in the global vaccination effort.
A ceremony marking the mRNA tech transfer announcement was to be held Friday in Brussels at the summit between the European Union and the African Union.
European Commission chief Ursula von der Leyen said: “We have been talking a lot about producing mRNA vaccines in Africa. But this goes even beyond. This is mRNA technology designed in Africa, led by Africa and owned by Africa.”
Currently only one percent of the vaccines used in Africa are produced on the continent of some 1.3 billion people.
The WHO set up a global mRNA technology transfer hub in South Africa last year to support manufacturers in low- and middle-income countries to produce their own vaccines.
The global hub’s role is to ensure that manufacturers in those nations have the know-how to make mRNA vaccines at scale and according to international standards.
As used in the Pfizer/BioNTech and Moderna COVID-19 vaccines, mRNA technology provokes an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells.
Primarily set up to address the COVID-19 pandemic, the global hub has the potential to expand manufacturing capacity for other vaccines and products, such as insulin to treat diabetes, cancer medicines and, potentially, vaccines for diseases such as malaria, tuberculosis and HIV.
The scheme’s ultimate goal is to spread capacity for national and regional production to all health technologies.
The WHO said it would work with the first six countries chosen to develop a roadmap of training and support so they can start producing vaccines as soon as possible. Training will begin in March.
The South African hub is already producing mRNA vaccines at laboratory scale and is currently scaling up toward commercial scale.
South African President Cyril Ramaphosa said Friday’s announcement “means mutual respect, mutual recognition of what we can all bring to the party, investment in our economies, infrastructure investment and, in many ways, giving back to the continent.”
French President Emmanuel Macron said supporting African health sovereignty was one of the key goals of starting up local production, “to empower regions and countries to fend for themselves, during crises, and in peace time.”
More than 10.4 billion COVID-19 vaccine doses have been administered around the world, with nearly 62 percent of the global population having received at least one shot.
However, just 11.3 percent of Africans had been fully immunized by the start of February.
rjm/jv
Six African countries to get own mRNA jab production
https://arab.news/rwq3c
Six African countries to get own mRNA jab production
- The scheme’s ultimate goal is to spread capacity for national and regional production to all health technologies
UK pays Guantanamo detainee ‘substantial’ compensation over US torture questions
- Abu Zubaydah has been held at Guantanamo Bay without charge for 20 years
- British security services knew he was subjected to ‘enhanced interrogation’ but failed to raise concerns for 4 years
LONDON: A Saudi-born Palestinian being held without trial by the US has received a “substantial” compensation payment from the UK government, the BBC reported.
Abu Zubaydah has been imprisoned at Guantanamo Bay in Cuba for almost 20 years following his capture in Pakistan in 2002, and was subjected to “enhanced interrogation” techniques by the CIA.
He was accused of being a senior member of Al-Qaeda in the aftermath of the Sept. 11 terror attacks on the US. The allegations were later dropped but he remains in detention.
The compensation follows revelations that UK security services submitted questions to the US to be put to Abu Zubaydah by their US counterparts despite knowledge of his mistreatment.
He alleged that MI5 and MI6 had been “complicit” in torture, leading to a legal case and the subsequent compensation.
Dominic Grieve, the UK’s former attorney general, chaired a panel reviewing Abu Zubaydah’s case.
He described the compensation as “very unusual” but said the treatment of Abu Zubaydah had been “plainly” wrong, the BBC reported.
Grieve added that the security services had evidence that the “Americans were behaving in a way that should have given us cause for real concern,” and that “we (UK authorities) should have raised it with the US and, if necessary, closed down co-operation, but we failed to do that for a considerable period of time.”
Abu Zubaydah’s international legal counsel, Prof. Helen Duffy, said: “The compensation is important, it’s significant, but it’s insufficient.”
She added that more needs to be done to secure his release, stating: “These violations of his rights are not historic, they are ongoing.”
Duffy said Abu Zubaydah would continue to fight for his freedom, adding: “I am hopeful that the payment of the substantial sums will enable him to do that and to support himself when he’s in the outside world.”
He is one of 15 people still being held at Guantanamo, many without charge. Following his initial detention, he arrived at the prison camp having been the first person to be taken to a so-called CIA “black site.”
He spent time at six such locations, including in Lithuania and Poland, outside of US legal jurisdiction.
Internal MI6 messages revealed that the “enhanced interrogation” techniques he was subjected to would have “broken” the resolve of an estimated 98 percent of US special forces members had they been subjected to them.
CIA officers later decided he would be permanently cut off from the outside world, with then-President George W. Bush publicly saying Abu Zubaydah had been “plotting and planning murder.”
However, the US has since withdrawn the allegations and no longer says he was a member of Al-Qaeda.
A report by the US Senate Select Committee on Intelligence said Abu Zubaydah had been waterboarded at least 83 times, was locked in a coffin-like box for extended periods, and had been regularly assaulted. Much of his treatment would be considered torture under UK law.
Despite knowledge of his treatment, it was four years before British security services raised concerns with their American counterparts, and their submission of questions within that period had “created a market” for the torture of detainees, Duffy said.
A 2018 report by the UK Parliament’s Intelligence and Security Committee was deeply critical of the behavior of MI5 and MI6 in relation to Abu Zubaydah.
It also criticized conduct relating to Guantanamo detainee Khalid Sheikh Mohammed, widely regarded as a key architect of the Sept. 11 attacks, warning that the precedent set by Abu Zubaydah’s legal action could be used by Mohammed to bring a separate case against the UK.
MI5 and MI6 failed to comment on Abu Zubaydah’s case. Neither the UK government nor Mohammed’s legal team would comment on a possible case over his treatment.
